niacinamide has been researched along with Multiple Sclerosis in 5 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This brief report develops the ideas of some previous works underlying a possible functional disequilibrium of tryptophan metabolism in patients affected by Multiple Sclerosis (M." | 3.65 | N1-Methylnicotinamide urinary output in multiple sclerosis affected patients. ( Altamura, AC; Sacchetti, E; Smeraldi, E; Zibetti, A, 1975) |
| "Multiple sclerosis is an autoimmune disease of the central nervous system characterized by neuroinflammation and demyelination." | 1.37 | Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis. ( Crespo, O; Daneman, R; Ho, PP; Kang, SC; Lindstrom, TM; Robinson, WH; Sobel, RA; Steinman, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crespo, O | 1 |
| Kang, SC | 1 |
| Daneman, R | 1 |
| Lindstrom, TM | 1 |
| Ho, PP | 1 |
| Sobel, RA | 1 |
| Steinman, L | 1 |
| Robinson, WH | 1 |
| Sacchetti, E | 1 |
| Altamura, AC | 1 |
| Smeraldi, E | 1 |
| Zibetti, A | 1 |
| Matheson, NA | 1 |
| Husemann, F | 1 |
| Kugler, J | 1 |
| Frank, I | 1 |
| Schwarz, D | 1 |
1 trial available for niacinamide and Multiple Sclerosis
| Article | Year |
|---|---|
[Relaxation-promoting effect of vitamin B with anabolics].
Topics: Action Potentials; Adult; Anabolic Agents; Androstanes; Attention; Blood Pressure; Cerebral Hemorrha | 1970 |
4 other studies available for niacinamide and Multiple Sclerosis
| Article | Year |
|---|---|
Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
Topics: Animals; Anisoles; Astrocytes; Benzamides; Benzenesulfonates; Cell Differentiation; Cell Proliferati | 2011 |
N1-Methylnicotinamide urinary output in multiple sclerosis affected patients.
Topics: Adult; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Niacinamide; Tryptophan | 1975 |
Letter: Multiple sclerosis and diet.
Topics: Ascorbic Acid; Calcium, Dietary; Drug Therapy, Combination; Humans; Magnesium; Male; Multiple Sclero | 1974 |
[Microcirculatory therapy of multiple sclerosis].
Topics: Adult; Ascorbic Acid; Blood Circulation; Blood Coagulation; Diet Therapy; Female; Humans; Male; Midd | 1970 |